Navigation Links
UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
Date:11/12/2012

anderbilt University School of Medicine, and Ralph Baric, Ph.D., professor of Microbiology, Immunology and Epidemiology at the University of North Carolina at Chapel Hill's Gillings School of Global Public Health. The researchers' aim is to better understand how coronaviruses, which also cause the common cold, evolve and spread between species.

Denison's lab developed the attenuated SARS virus by disabling a unique exoribonuclease (or ExoN) protein, referred to as a proofreading protein. Previous Vanderbilt studies had shown that disabling ExoN knocks out the virus's ability to correct mistakes, increases mutations twentyfold, and stops its ability to cause disease, at least in the lab setting. Graham, formerly a graduate student in Denison's lab, was able to continue the work in animal models as a postdoctoral scientist in Baric's lab.

Coronaviruses are RNA viruses known to have the largest genomes in the RNA viral world. It is now understood that the ExoN proofreading protein allows coronaviruses to maintain their expanded genomes, with many proteins evolved to help them survive and spread. But deactivation of ExoN creates a particularly enticing potential approach to vaccine design.

"Live vaccines in general confer broader and longer-lasting immunity, but the risk of live vaccines is they could potentially revert back to virulence as happened with the live polio vaccine in immunocompromised people," Baric said. "Our evidence is exciting because a more permanently attenuated virus might be safer. We believe that related approaches can be applied to other important human and animal viruses, resulting in safer vaccines."

To test the likelihood of reversion to virulence, researchers allow a virus to grow in a host that lacks immunity. In the current study, even in very young, very old and immunocompromised animals, the virus did not kill and could persist for a long time without showing signs of a return to virulence.

"In
'/>"/>

Contact: Carole Bartoo
carole.bartoo@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Vanderbilt study finds obesity linked to kidney injury after heart surgery
2. Vanderbilt researchers find proteins may point way to new prostate cancer drug targets
3. Vanderbilt-led study reveals racial disparities in prostate cancer care
4. Vanderbilt study looks at benefits of progestogens to prevent early childbirth
5. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
6. Washingtons Life Sciences Discovery Fund awards commercialization grants
7. Discovery could help to develop drugs for organ transplant and cancer patients
8. Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments
9. IBN discovers human neural stem cells with tumor targeting ability
10. H1N1 discovery paves way for universal flu vaccine: UBC research
11. Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 Many people, including the ones ... climbing, and cycling are only for able-bodied participants. ... Rehabilitation Institute aims to change that thinking. , ... host an Adaptive Sports Expo on Saturday, April 11 ... South in Hollywood. , The event will showcase ...
(Date:3/31/2015)... 31, 2015 On March 26, 2015, Vogue ... the Silicone Slope?” provides a look into the trend of ... and laser treatments . The article suggests that celebrity ... stars such as Kim Kardashian and Kylie Jenner are the ... increasingly seen as significant influences on the self-esteem of teenagers. ...
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 Dr. Russell ... for Advanced Reconstruction. He was recently quoted in an ... caused by lymphatic issues, causing fluid retention and tissue swelling. ... procedure to relieve and / or improve lymphedema symptoms. ... improve or alleviate the symptoms of lymphedema. The goal ...
(Date:3/31/2015)... Beckman Coulter is sponsoring a new educational webinar ... in Therapeutic Protein Injections”,” an educational session that will describe ... in liquids, with a focus on the challenges of preparing ... and will be broadcast live April 8, 2015 at 7:00am ... protein-based materials, known as USP 787 , and indicated ...
(Date:3/31/2015)... 31, 2015 National Adaptive Sports ... and psychological benefits of participating in adaptive sports ... adaptive sports athletes that adapt, believe and compete ... for inclusive fitness and inclusive athletics in our ... in adaptive sports and advocate for an increase ...
Breaking Medicine News(10 mins):Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3
... CORDOVA, Calif., Aug. 6 ThermoGenesis Corp. (Nasdaq: ... and storing adult stem cells, announced today the introduction of the ... for the concentration of bone marrow-derived stem cells at the point ... processes bone marrow in minutes and delivers a high rate of ...
... , MAARSSEN, Netherlands, Aug. 6 Against ... the second CPhI South America and P-MEC South America pharma ingredients ... , , Staged by UBM International Media, ... and nearly 4,500 attendees. Argentina, India and the USA headed the ...
... , MAARSSEN, The Netherlands, Aug. 6: Numbers were ... China and P-MEC China ... opportunity for the pharma ingredients, services and production equipment communities. , ... 23 - 25 June, the combined events hosted 1,651 exhibitors from 17 countries ...
... , , , HOUSTON, ... nation,s leading producer of Omega-3 fish oil and specialty fish meal products, ... second quarter of 2009, compared with net income of $6.7 million ($0.37 ... , Revenues for the second quarter ended June 30, 2009 ...
... could be causing gut inflammation, study suggests, , THURSDAY, Aug. ... mouth, skin and intestines might play a role in the ... , Researchers found the bacterium Klebsiella ... in their study who had colic, a condition characterized by ...
... ... Syndrome Foundation, www.angelman.org , announced the formation of the Angelman ... increasing research funding. The ATRI will also serve as a hub ... discoveries and treatments for this neuro-genetic disorder. The announcement of the ...
Cached Medicine News:Health News:ThermoGenesis Announces Launch of Res-Q System; New Device Expands Company's Presence in Bone Marrow Sector 2Health News:ThermoGenesis Announces Launch of Res-Q System; New Device Expands Company's Presence in Bone Marrow Sector 3Health News:Sao Paulo Hosts Second CPhI and P-MEC South America Pharma Events 2Health News:Sao Paulo Hosts Second CPhI and P-MEC South America Pharma Events 3Health News:China Pharma Events Keep Growing For UBM 2Health News:China Pharma Events Keep Growing For UBM 3Health News:Omega Protein Reports 2009 Second Quarter Results 2Health News:Omega Protein Reports 2009 Second Quarter Results 3Health News:Omega Protein Reports 2009 Second Quarter Results 4Health News:Omega Protein Reports 2009 Second Quarter Results 5Health News:Omega Protein Reports 2009 Second Quarter Results 6Health News:Bacteria May Be Connected to Colic 2Health News:Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 2Health News:Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 3
(Date:3/31/2015)... ANGELES , March 31, 2015  On ... mesothelioma will convene in Santa Monica, ... Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma ... from exposure to asbestos and commonly affects the ... is co-hosted by UCLA and the Pacific Mesothelioma ...
(Date:3/31/2015)... , March 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ... developing premium quality medical marijuana products and a licensed ... Medical Purposes Regulations ( Canada ) ("MMPR"), ... from The Corporation of the District of ... the Company,s premises which now allows for commercial distribution ...
(Date:3/31/2015)... Minn. , March 31, 2015 ANI ... the launch of Propafenone Hydrochloride 150mg, 225mg and 300mg ... various arrhythmias. The overall US market for Propafenone Hydrochloride ... 2014, per IMS Health. Arthur S. ... are pleased to announce the launch of our fourth ...
Breaking Medicine Technology:Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3
... N.J., Dec. 17, 2010 Par Pharmaceutical Companies, Inc. (NYSE: ... has resigned his positions as President of Strativa Pharmaceuticals and ... interests effective January 31, 2011 .  Patrick G. LePore, ... oversight of Strativa on an interim basis. ...
... Inc. (Nasdaq: ESRX ), today announced plans ... area — the third office building and fourth facility ... (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ) The ... that found Express Scripts generates about $1 billion in ...
Cached Medicine Technology:John A. MacPhee Resigns From Strativa Pharmaceuticals 2Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus 2Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus 3
... to detect sequences of the following ... 2 and 3; influenza virus A ... A and B. Laboratories may ... tests., *Analyte Specific Reagents. ...
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...
... offers reagents for the detection of ... the G1691A mutation on the Factor ... mutation on the Prothrombin gene. Laboratories ... homebrew tests.,, *Analyte Specific ...
Medicine Products: